Clovis Oncology, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boulder, CO
SEC filing record 1 source field available
Fiscal year end
31 December
Clovis Oncology, Inc. has filed 952 SEC EDGAR filings since 25 Jun 2009

SEC filing history

Showing 876-900 of 951 matching filings.

Per page
25
Current page
36
4

4 filing

Filing date
22 Nov 2011
Reporting date
21 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Nov 2011
Reporting date
21 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Nov 2011
Reporting date
21 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Nov 2011
Reporting date
21 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Nov 2011
Reporting date
21 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Nov 2011
Reporting date
21 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Nov 2011
Reporting date
21 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Nov 2011
Reporting date
21 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Nov 2011
Reporting date
21 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
21 Nov 2011
Reporting date
21 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Nov 2011
Reporting date
21 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Nov 2011
Reporting date
21 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Nov 2011
Reporting date
21 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Nov 2011
Reporting date
21 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Nov 2011
Reporting date
21 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Nov 2011
Reporting date
21 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Nov 2011
Reporting date
21 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Nov 2011
Reporting date
21 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-86488

SCHED 13D FOR CLOVIS ONCOLOGY BY DOMAIN PARTNERS VII

Filing date
21 Nov 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
21 Nov 2011
Reporting date
21 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
21 Nov 2011
Reporting date
21 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
21 Nov 2011
Reporting date
21 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
21 Nov 2011
Reporting date
21 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
21 Nov 2011
Reporting date
21 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
17 Nov 2011
Reporting date
16 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .